Achromatopsia is an inherited retinal disease causing loss of visual acuity as well as central and color vision and vision in lighted conditions.
What is Achromatopsia?
Achromatopsia is an inherited retinal condition causing extreme light sensitivity (i.e., day blindness), as well as reduced visual acuity and color discrimination. Achromatopsia is caused by mutations in any of several genes. The most common genes associated with the condition are the CNGB3 and CNGA3 genes — mutations in these cause about 75 percent of cases.
Symptoms
Achromatopsia causes extreme light sensitivity (i.e., day blindness), as well as reduced visual acuity and color discrimination. People with the condition wear glasses with tinted lenses to filter out the type of light that is uncomfortable. Different patients have different light-filtering needs.
Inheritance
Achromatopsia is caused by mutations in one of a few genes. The most common genes associated with the condition are the CNGB3 and CNGA3 genes — mutations in these cause about 75 percent of cases. Mutations in GNAT2, PDE6C, and PDE6H can also cause the disease.
The condition is passed down through the autosomal recessive inheritance pattern. In autosomal recessive diseases, both parents carry one copy of the mutated gene and one normal copy, but have no symptoms themselves. They are therefore referred to as unaffected carriers. Each of their children has a 25 percent chance of being affected by inheriting a mutated copy from each parent. If the child inherits one mutated copy from one parent, they will be an unaffected carrier.
Living with the Disease
There are many services and accommodative and assistive resources available to people and families with achromatopsia. Visit the Foundation’s Low Vision Resources page to learn about many of these resources. A low vision specialist can help recommend the resources that are right for you.
Genetic Testing
Genetic testing is available for achromatopsia. It helps assess the risk of passing the disorder from parent to offspring. It also helps with attaining an accurate diagnosis. A patient with an accurate diagnosis is in a better position to understand which emerging treatment approaches and clinical trials are most appropriate for them.
What treatment is available?
View a list of current clinical trials, many made possible by Foundation support.
Achromatopsia page at www.ClinicalTrials.gov.
AGTC has developed a new website as a resource for the achromatopsia community. The website includes information on their trials and also answers frequently asked questions on gene therapy and clinical trials.
Next Section
Jump to Section
Latest News
-
Aug 21, 2020
Foundation Fighting Blindness Commits $6.5 Million for New Retinal Disease Research Grants
New grants include development of CRISPR/Cas9 gene-editing treatments, new disease models, and a retinal regeneration therapy
-
Mar 31, 2020
COVID-19 Resources
The Foundation Fighting Blindness is closely monitoring the COVID-19 situation and its impact on the IRD community.
-
Feb 6, 2020
ProQR Therapeutics Teams Up with the Foundation Fighting Blindness and Blueprint Genetics to Support the My Retina Tracker® Program for People Living with Inherited Retinal Diseases
My Retina Tracker Program is the highest volume IRD genetic testing program in the U.S.
-
Oct 2, 2019
Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness launch an open access program for patients with inherited retinal disease in the United States
The program will offer patients with inherited retinal disease no-cost genetic testing and genetic counseling in the United States. Look for updated information on how to participate to be posted in mid-October, with program registration starting shortly thereafter.
-
May 9, 2019
Foundation Fighting Blindness Endorses 'Eye Bonds' Legislation
Bipartisan Bill Will Stimulate Up to $1 Billion in New Funding for Blindness Research
-
Jul 19, 2018
Foundation Fighting Blindness Urges Congress to Pass ‘Eye-Bonds’ Legislation
Bill Introduced in U.S. House Would Speed Up Cures for Blindness
-
Jun 8, 2018
Foundation Fighting Blindness and CheckedUp® Partner to Educate Retinal-Disease Patients About Research, Resources, and Emerging Therapies During Doctor Visits
The Foundation Fighting Blindness (the Foundation) and CheckedUp have formed a collaborative partnership to deliver patient-friendly diagnostic and disease-management information to people with retinal diseases such as age-related macular degeneration, retinitis pigmentosa, and Stargardt disease during their visits to eye doctors.